Incidence and risk of peripheral neuropathy with nab-paclitaxel in patients with cancer: a meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence and risk of peripheral neuropathy with nab-paclitaxel in patients with cancer: a meta-analysis

Published:2015-11-04 Issue:5 Volume:26 Page:e12407
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Peng L.¹,Bu Z.²,Ye X.³,Zhou Y.⁴,Zhao Q.¹

Affiliation:

1. Department of Thoracic Oncology; The First Affiliated Hospital; School of Medicine; Zhejiang University; Hangzhou China

2. Department of Ultrasound; Zhejiang Hospital; Hangzhou China

3. Department of Radiation; The First Affiliated Hospital; School of Medicine; Zhejiang University; Hangzhou China

4. Zhejiang Food and Drug Administration; Hangzhou China

Funder

Natural Science Foundation of Zhejiang Province

State Administration of Traditional Chinese Medicine of the People's Republic of China

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12407/fullpdf

Reference42 articles.

1. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: a gynecologic oncology group study;Alberts;Gynecologic Oncology,2012

2. Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence;Balayssac;Expert Opinion on Drug Safety,2011

3. Operating characteristics of a rank correlation test for publication bias;Begg;Biometrics,1994

4. Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes;Blum;Clinical Breast Cancer,2007

5. Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials;Choueiri;Journal of Clinical Oncology,2010

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An up-to-date view of paclitaxel-induced peripheral neuropathy;Journal of Cancer Research and Therapeutics;2023-12

2. COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms;Medicinal Research Reviews;2023-11-21

3. Effectiveness, safety, and impact on quality of life of eribulin‐based therapy in heavily pretreated patients with metastatic breast cancer: A real‐world analysis;Cancer Medicine;2023-07-05

4. A retrospect study based on real-world data to observe metabolic function in cancer patients using albumin-bound paclitaxel;Scientific Reports;2023-06-03

5. A Prospective, Randomized, Placebo-Controlled Study Assessing the Efficacy of Chinese Herbal Medicine (Huangqi Guizhi Wuwu Decoction) in the Treatment of Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy;Journal of Clinical Medicine;2023-01-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3